138 related articles for article (PubMed ID: 11148558)
1. Frequent nuclear accumulation of beta-catenin in pituitary adenoma.
Semba S; Han SY; Ikeda H; Horii A
Cancer; 2001 Jan; 91(1):42-8. PubMed ID: 11148558
[TBL] [Abstract][Full Text] [Related]
2. Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.
Tziortzioti V; Ruebel KH; Kuroki T; Jin L; Scheithauer BW; Lloyd RV
Endocr Pathol; 2001; 12(2):125-36. PubMed ID: 11579678
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis.
Garcia-Rostan G; Camp RL; Herrero A; Carcangiu ML; Rimm DL; Tallini G
Am J Pathol; 2001 Mar; 158(3):987-96. PubMed ID: 11238046
[TBL] [Abstract][Full Text] [Related]
4. Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1.
Sun C; Yamato T; Kondo E; Furukawa T; Ikeda H; Horii A
J Neurooncol; 2005 Jun; 73(2):131-4. PubMed ID: 15981102
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumors.
Bonnet S; Gaujoux S; Launay P; Baudry C; Chokri I; Ragazzon B; Libé R; René-Corail F; Audebourg A; Vacher-Lavenu MC; Groussin L; Bertagna X; Dousset B; Bertherat J; Tissier F
J Clin Endocrinol Metab; 2011 Feb; 96(2):E419-26. PubMed ID: 21084400
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies.
Xu B; Sano T; Yoshimoto K; Yamada S
Endocr Pathol; 2002; 13(4):341-51. PubMed ID: 12665652
[TBL] [Abstract][Full Text] [Related]
7. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
8. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
9. Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.
Jo VY; Sholl LM; Krane JF
Am J Surg Pathol; 2016 Aug; 40(8):1143-50. PubMed ID: 27259009
[TBL] [Abstract][Full Text] [Related]
10. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
11. More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages.
Yanagisawa N; Mikami T; Saegusa M; Okayasu I
Cancer Res; 2001 Jan; 61(1):19-22. PubMed ID: 11196159
[TBL] [Abstract][Full Text] [Related]
12. Nuclear β-catenin expression in basal cell adenomas of salivary gland.
Kawahara A; Harada H; Abe H; Yamaguchi T; Taira T; Nakashima K; Mihashi H; Akiba J; Kage M
J Oral Pathol Med; 2011 Jul; 40(6):460-6. PubMed ID: 21323741
[TBL] [Abstract][Full Text] [Related]
13. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.
Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY
Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702
[TBL] [Abstract][Full Text] [Related]
14. CTNNB1 mutations in basal cell adenoma of the salivary gland.
Lee YH; Huang WC; Hsieh MS
J Formos Med Assoc; 2018 Oct; 117(10):894-901. PubMed ID: 29224720
[TBL] [Abstract][Full Text] [Related]
15. Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study.
Oyama Y; Nishida H; Kusaba T; Kadowaki H; Arakane M; Wada J; Urabe S; Hirano T; Kawano K; Suzuki M; Yokoyama S; Daa T
Diagn Pathol; 2018 Jul; 13(1):48. PubMed ID: 30053869
[TBL] [Abstract][Full Text] [Related]
16. Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-catenin.
Imai M; Nakamura T; Akiyama T; Horii A
Oncol Rep; 2004 Nov; 12(5):1099-103. PubMed ID: 15492799
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.
Jungck M; Grünhage F; Spengler U; Dernac A; Mathiak M; Caspari R; Friedl W; Sauerbruch T
Int J Colorectal Dis; 2004 Sep; 19(5):438-45. PubMed ID: 14986031
[TBL] [Abstract][Full Text] [Related]
18. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
[TBL] [Abstract][Full Text] [Related]
20. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
Saldanha G; Ghura V; Potter L; Fletcher A
Br J Dermatol; 2004 Jul; 151(1):157-64. PubMed ID: 15270885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
